Search research articles
Contact Us
Filters
Showing results (171-180 of 191) with videos related to
Page
of 20
Sort By:
The Lancet. Respiratory Medicine
|
January 28, 2014
Global differences in lung function by region (PURE): an international, community-based prospective study
MyLinh Duong, Shofiqul Islam, Sumathy Rangarajan, et al.
Lancet (London, England)
|
September 1, 2021
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis
Philip Joseph, Gholamreza Roshandel, Peggy Gao, et al.
Lancet (London, England)
|
June 22, 2010
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study
Martin J O'Donnell, Denis Xavier, Lisheng Liu, et al.
JAMA
|
September 5, 2013
Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries
Clara K Chow, Koon K Teo, Sumathy Rangarajan, et al.
The New England Journal of Medicine
|
August 15, 2014
Urinary sodium and potassium excretion, mortality, and cardiovascular events
Martin O'Donnell, Andrew Mente, Sumathy Rangarajan, et al.
JAMA
|
March 16, 2015
Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial
Yong Huo, Jianping Li, Xianhui Qin, et al.
European Heart Journal
|
May 8, 2021
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
Jackie Bosch, Eva M Lonn, Hyejung Jung, et al.
The Canadian Journal of Cardiology
|
October 21, 2015
Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics
Eva Lonn, Jackie Bosch, Janice Pogue, et al.
The New England Journal of Medicine
|
April 5, 2016
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
Salim Yusuf, Eva Lonn, Prem Pais, et al.
The New England Journal of Medicine
|
April 5, 2016
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Salim Yusuf, Jackie Bosch, Gilles Dagenais, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 191) with videos related to
Sort By:
Page
of 20
The Lancet. Respiratory Medicine
|
January 28, 2014
Global differences in lung function by region (PURE): an international, community-based prospective study
MyLinh Duong, Shofiqul Islam, Sumathy Rangarajan, et al.
Lancet (London, England)
|
September 1, 2021
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis
Philip Joseph, Gholamreza Roshandel, Peggy Gao, et al.
Lancet (London, England)
|
June 22, 2010
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study
Martin J O'Donnell, Denis Xavier, Lisheng Liu, et al.
JAMA
|
September 5, 2013
Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries
Clara K Chow, Koon K Teo, Sumathy Rangarajan, et al.
The New England Journal of Medicine
|
August 15, 2014
Urinary sodium and potassium excretion, mortality, and cardiovascular events
Martin O'Donnell, Andrew Mente, Sumathy Rangarajan, et al.
JAMA
|
March 16, 2015
Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial
Yong Huo, Jianping Li, Xianhui Qin, et al.
European Heart Journal
|
May 8, 2021
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
Jackie Bosch, Eva M Lonn, Hyejung Jung, et al.
The Canadian Journal of Cardiology
|
October 21, 2015
Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics
Eva Lonn, Jackie Bosch, Janice Pogue, et al.
The New England Journal of Medicine
|
April 5, 2016
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
Salim Yusuf, Eva Lonn, Prem Pais, et al.
The New England Journal of Medicine
|
April 5, 2016
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Salim Yusuf, Jackie Bosch, Gilles Dagenais, et al.
Page
of 20